Inhibition of joint damage and improved clinical outcomes with rituximab plus methotrexate in early active rheumatoid arthritis: the IMAGE trial. [electronic resource]
Producer: 20110318Description: 39-46 p. digitalISSN:- 1468-2060
- Adolescent
- Adult
- Aged
- Aged, 80 and over
- Antibodies, Monoclonal, Murine-Derived -- therapeutic use
- Antirheumatic Agents -- therapeutic use
- Arthritis, Rheumatoid -- drug therapy
- Disease Progression
- Double-Blind Method
- Drug Administration Schedule
- Drug Therapy, Combination -- methods
- Humans
- Methotrexate -- therapeutic use
- Middle Aged
- Rituximab
- Severity of Illness Index
- Treatment Outcome
- Young Adult
No physical items for this record
Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.